Menu Search
Equities

Victrex PLC

1OY:DEU

Victrex PLC

Actions
  • Price (EUR)18.20
  • Today's Change0.300 / 1.68%
  • Shares traded0.00
  • 1 Year change-8.54%
  • Beta--
Data delayed at least 15 minutes, as of Jun 02 2023 14:31 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Victrex plc is a United Kingdom-based holding company. The principal activity of the Company is the manufacturing and selling of high-performance polymers. The Company develops polyetheretherketone (PEEK) and PAEK polymer solutions, and semi-finished and finished parts. The Company operates through two segments: Industrial and Medical. Industrial segment is focuses on its energy and industrial, value-added resellers (VAR), automotive, aerospace, and electronics markets. Medical segment is focuses on providing specialist solutions for medical device manufacturers. The Company’s subsidiaries include Victrex Manufacturing Limited, Invibio Limited, Invibio Knees Limited, Invibio Device Component Manufacturing Limited and Juvora Limited.

  • Revenue in GBP (TTM)332.40m
  • Net income in GBP72.10m
  • Incorporated1993
  • Employees1.09k
  • Location
    Victrex PLCVictrex Technology Centre, Hillhouse International,THORNTON CLEVELEYS FY5 4QDUnited KingdomGBR
  • Phone+44 125 389 7700
  • Fax+44 125 389 7701
  • Websitehttps://www.victrexplc.com/
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.